Protective effect of L-arginine against nephrotoxicity induced by cyclosporine in normal rats

被引:30
作者
Mansour, M
Daba, MH
Gado, A
Al-Rikabi, A
Al-Majed, A
机构
[1] King Saud Univ, Fac Pharm, Dept Pharmacol, Riyadh 11451, Saudi Arabia
[2] King Saud Univ, Fac Pharm, Dept Clin Pharm, Riyadh 11451, Saudi Arabia
[3] King Saud Univ, Fac Med, Dept Pathol, Riyadh 11451, Saudi Arabia
关键词
aminoguanidine; L-arginine; cyclosporine; oxidative stress; nephrotoxicity;
D O I
10.1006/phrs.2002.0968
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Effects of L-arginine (L-arg) and aminoguanidine (AG) on the nephrotoxicity induced by cyclosporine (CsA) were investigated. After injection of CsA (15 mg kg(-1) day(-1) i.p. for 10 days), it induced nephrotoxicity, manifested biochemically by a significant elevation of serum urea and creatinine. In addition, a marked increase in lipid peroxides measured as malondialdehyde (MDA) as well as a significant decrease in glutathione peroxidase (GSH-Px) activity (EC.1.11.1.9) and reduced glutathione content (GSH) in kidney tissues homogenate were observed. Nephrotoxicity was further confirmed by histopathological investigation. Oral administration of L-arg (300 mg kg(-1) day(-1) orally) for 5 days before and 10 days concomitant with CsA injection produced a significant protection against nephrotoxity induced by CsA. The amelioration of nephrotoxicity was evidenced by significant reductions in serum urea and creatinine concentrations. In addition, L-arg prevented the rise of MDA as well as reduction of GSH-Px activity and reduced GSH content in kidney tissue. The protective effects of L-arg against CsA-induced nephrotoxicity were further confirmed by histopathological examination. However, oral supplementation of AG (100 mg kg(-1) day(-1) p.o.) did not protect the kidney from the damaging effects of CsA. These results suggest that L-arg can ameliorate kidney dysfunction induced by CsA via a mechanism(s) which involves the production of nitric oxide. In addition, L-arg may therefore be a beneficial remedy for CsA nephrotoxicity and can be used to improve the therapeutic index of CsA. (C) 2002 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:441 / 446
页数:6
相关论文
共 33 条
[1]   A POSSIBLE ROLE FOR NITRIC-OXIDE IN MODULATING THE FUNCTIONAL CYCLOSPORINE TOXICITY BY ARGININE [J].
AMORE, A ;
GIANOGLIO, B ;
GHIGO, D ;
PERUZZI, L ;
PORCELLINI, MG ;
BUSSOLINO, F ;
COSTAMAGNA, C ;
CACACE, G ;
PICCIOTTO, G ;
MAZZUCCO, G ;
SENA, LM ;
COPPO, R .
KIDNEY INTERNATIONAL, 1995, 47 (06) :1507-1514
[2]   Nitric oxide mediates cyclosporine-induced apoptosis in cultured renal cells [J].
Amore, A ;
Emanicpator, SN ;
Cirina, P ;
Conti, G ;
Ricotti, E ;
Bagheri, N ;
Coppo, R .
KIDNEY INTERNATIONAL, 2000, 57 (04) :1549-1559
[3]   Protective effects of dietary L-arginine supplementation on chronic cyclosporine nephrotoxicity [J].
Andoh, TF ;
Gardner, MP ;
Bennett, WM .
TRANSPLANTATION, 1997, 64 (09) :1236-1240
[4]   Cocaine-induced liver injury in mice is mediated by nitric oxide and reactive oxygen species [J].
Aoki, K ;
Ohmori, M ;
Takimoto, M ;
Ota, H ;
Yoshida, T .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1997, 336 (01) :43-49
[5]   L-arginine and allopurinol protect against cyclosporine nephrotoxicity [J].
Assis, SM ;
Monteiro, JL ;
Seguro, AC .
TRANSPLANTATION, 1997, 63 (08) :1070-1073
[6]   SERUM CREATININE DETERMINATION WITHOUT PROTEIN PRECIPITATION [J].
BARTELS, H ;
BOHMER, M ;
HEIERLI, C .
CLINICA CHIMICA ACTA, 1972, 37 (NMAR) :193-&
[7]   THE EFFECT OF ARGININE AND NITRIC-OXIDE ON RESISTANCE BLOOD-VESSELS OF THE PERFUSED RAT-KIDNEY [J].
BHARDWAJ, R ;
MOORE, PK .
BRITISH JOURNAL OF PHARMACOLOGY, 1989, 97 (03) :739-744
[8]   AN EXPERIMENTAL-STUDY OF ALTERED NITRIC-OXIDE METABOLISM AS A MECHANISM OF CYCLOSPORINE-INDUCED RENAL VASOCONSTRICTION [J].
BLOOM, ITM ;
BENTLEY, FR ;
SPAIN, DA ;
GARRISON, RN .
BRITISH JOURNAL OF SURGERY, 1995, 82 (02) :195-198
[9]   ROLE OF NITRIC-OXIDE IN RENAL HEMODYNAMIC ABNORMALITIES OF CYCLOSPORINE NEPHROTOXICITY [J].
BOBADILLA, NA ;
TAPIA, E ;
FRANCO, M ;
LOPEZ, P ;
MENDOZA, S ;
GARCIATORRES, R ;
ALVARADO, JA ;
HERRERAACOSTA, J .
KIDNEY INTERNATIONAL, 1994, 46 (03) :773-779
[10]  
CERNADAS MR, 1992, J PHARMACOL EXP THER, V263, P1023